AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22080174 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-reactive antibody response
Number of subjects: 110
Study 22080174 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistence of antibodies
Number of subjects: 110
Study 22080174 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety of the vaccine
Number of subjects: 110
Study 20730486 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane withdrawal
Number of subjects: 206
Study 20730486 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen withdrawal
Number of subjects: 206
Study 20730486 — intervention group
Group type: COMPARATOR
Intervention: Exemestane treatment
Number of subjects: 206
Study 20730486 — intervention group
Group type: COMPARATOR
Intervention: Post-treatment fracture rates
Number of subjects: 206
Study 17656657 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel
Number of subjects: 56
Study 17656657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 16136769 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol (100/50 microg, twice daily)
Number of subjects: 0
Study 16136769 — intervention group
Group type: COMPARATOR
Intervention: Montelukast (once daily)
Number of subjects: 0
Study 12351465 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4 g daily for 8 weeks)
Number of subjects: 42
Study 12351465 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (4 g daily for 8 weeks)
Number of subjects: 42
Study 10614749 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilisation
Number of subjects: 50
Study 10614749 — intervention group
Group type: COMPARATOR
Intervention: Control (confined to bed for four days)
Number of subjects: 50
Study 7753691 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-step process improvement model for nursing home-acquired pneumonia management
Number of subjects: 0
Study 1780394 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychological treatment (problem-solving) given by a psychiatrist
Number of subjects: 0
Study 1780394 — intervention group
Group type: COMPARATOR
Intervention: Any treatment of the GP's choice (psychological or pharmacological)
Number of subjects: 0
Study 6761102 — intervention group
Group type: EXPERIMENTAL
Intervention: High calorie daily supplement (800 kcal and 40 g protein)
Number of subjects: 0
Study 6761102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30944021 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (70 micrograms daily)
Number of subjects: 0
Study 30944021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30387859 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewed Oxycodone DETERx fasted
Number of subjects: 71
Study 30387859 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewed Oxycodone DETERx fed
Number of subjects: 71
Study 30387859 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact Oxycodone DETERx fasted
Number of subjects: 71
Study 30387859 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact Oxycodone DETERx fed
Number of subjects: 71
Study 30387859 — intervention group
Group type: COMPARATOR
Intervention: Crushed IR oxycodone fasted
Number of subjects: 71
Study 26518108 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling protocol with the use of the monitoring-and-feedback tool (group 1, n=65)
Number of subjects: 131
Study 26518108 — intervention group
Group type: COMPARATOR
Intervention: Counselling protocol without the use of the monitoring-and-feedback tool (group 2, n=66)
Number of subjects: 131
Study 26518108 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling protocol (both groups)
Number of subjects: 131
Study 26518108 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling protocol with the use of the monitoring-and-feedback tool (group 1)
Number of subjects: 131
Study 26518108 — intervention group
Group type: COMPARATOR
Intervention: Counselling protocol without the use of the monitoring-and-feedback tool (group 2)
Number of subjects: 131
Study 24491000 — intervention group
Group type: COMPARATOR
Intervention: Skin staples for securing mesh
Number of subjects: 0
Study 24491000 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene suture for securing mesh
Number of subjects: 0
Study 23211228 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (90 minutes/day, 2 days/week for 6 months)
Number of subjects: 50
Study 23211228 — intervention group
Group type: COMPARATOR
Intervention: Control group (health promotion education classes, 2 classes over 6 months)
Number of subjects: 50
Study 21309477 — intervention group
Group type: COMPARATOR
Intervention: Closed circuit anaesthesia (CCA)
Number of subjects: 50
Study 21309477 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-closed circuit anaesthesia (SCA) 4 l/min
Number of subjects: 50
Study 17540986 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy monitoring during deep hypothermia with circulatory arrest
Number of subjects: 24
Study 17540986 — intervention group
Group type: COMPARATOR
Intervention: Near-infrared spectroscopy monitoring during moderate hypothermia
Number of subjects: 24
Study 17540986 — intervention group
Group type: COMPARATOR
Intervention: Near-infrared spectroscopy monitoring during deep hypothermia with low flow
Number of subjects: 24
Study 16244028 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine with 8.4% NaHCO3 (group large dose)
Number of subjects: 60
Study 16244028 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine with 1.4% NaHCO3 (group small dose)
Number of subjects: 60
Study 16244028 — intervention group
Group type: COMPARATOR
Intervention: Air (group air)
Number of subjects: 60
Study 12364905 — intervention group
Group type: EXPERIMENTAL
Intervention: Safer Sex Workshop
Number of subjects: 394
Study 12364905 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 394
Study 10209729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fornix-based conjunctival flap
Number of subjects: 29
Study 10209729 — intervention group
Group type: COMPARATOR
Intervention: Limbal-based conjunctival flap
Number of subjects: 29
Study 7607749 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyol gums (xylitol and sorbitol, or their combinations)
Number of subjects: 1787
Study 7607749 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% xylitol gums
Number of subjects: 1787
Study 7607749 — intervention group
Group type: COMPARATOR
Intervention: Other treatments (including sucrose gum)
Number of subjects: 1787
Study 2230911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g i.v.) at the time of anesthesia
Number of subjects: 52
Study 2230911 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (80 mg i.v.) at the time of anesthesia and two additional doses every 8 hours
Number of subjects: 52
Study 112630 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0
Study 112630 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 0
Study 112630 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 31987555 — intervention group
Group type: EXPERIMENTAL
Intervention: P30 (30 s rest)
Number of subjects: 15
Study 31987555 — intervention group
Group type: EXPERIMENTAL
Intervention: P60 (60 s rest)
Number of subjects: 15
Study 31987555 — intervention group
Group type: EXPERIMENTAL
Intervention: P90 (90 s rest)
Number of subjects: 15
Study 31987555 — intervention group
Group type: EXPERIMENTAL
Intervention: P120 (120 s rest)
Number of subjects: 15
Study 31702486 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg twice daily for 4 days followed by metoclopramide 20 mg
Number of subjects: 12
Study 28842913 — intervention group
Group type: EXPERIMENTAL
Intervention: Family conflict at 14 months
Number of subjects: 2876
Study 26237354 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Interferon gamma (IFN‐γ) for 80 weeks
Number of subjects: 10
Study 26237354 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 10
Study 23351309 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) 2.4 g/d
Number of subjects: 20
Study 23351309 — intervention group
Group type: COMPARATOR
Intervention: Guanidinoacetic acid (GAA) 2.4 g/d with methyl donors (1.6 g/d of betaine HCl, 5 μg/d of vitamin B12, 10 mg/d of vitamin B6, 600 μg/d of folic acid)
Number of subjects: 20
Study 21148235 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir 300/100 mg once daily
Number of subjects: 883
Study 21148235 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir 400/100 mg twice daily
Number of subjects: 883
Study 19258430 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (0.09 IU/kg body weight, 6 days/week for 3 weeks)
Number of subjects: 109
Study 19258430 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH withdrawal
Number of subjects: 109
Study 19258430 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rhGH treatment)
Number of subjects: 109
Study 17210983 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt endoscopy for patients over 55 years of age or with alarm symptoms
Number of subjects: 0
Study 17210983 — intervention group
Group type: COMPARATOR
Intervention: Various treatment options for dyspepsia
Number of subjects: 0
Study 15650345 — intervention group
Group type: COMPARATOR
Intervention: Premenopausal women with hFH
Number of subjects: 33
Study 15650345 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women with hFH
Number of subjects: 33
Study 15650345 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal hFH women with abnormal TG response (hFH-A)
Number of subjects: 33
Study 11194109 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate HBO (iHBO)
Number of subjects: 21
Study 11194109 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed HBO (dHBO)
Number of subjects: 21
Study 11194109 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study 9392462 — intervention group
Group type: EXPERIMENTAL
Intervention: CECT criteria
Number of subjects: 35
Study 9392462 — intervention group
Group type: EXPERIMENTAL
Intervention: APACHE II score
Number of subjects: 35
Study 7827373 — intervention group
Group type: EXPERIMENTAL
Intervention: octreotide (100 micrograms) s.c. administered 30 minutes before meals for 7 days
Number of subjects: 5
Study 7827373 — intervention group
Group type: COMPARATOR
Intervention: CCK-PZ and secretin (0.01 CHR U/kg/min)
Number of subjects: 5
Study 3278672 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CyA, 5 mg/kg/day)
Number of subjects: 194
Study 3278672 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (Aza, 2.5 mg/kg/day)
Number of subjects: 194
Study 3278672 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CyA)
Number of subjects: 194
Study 3278672 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (Aza)
Number of subjects: 194
Study 28993264 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual long-acting bronchodilator (umeclidinium/vilanterol - UME/VIL)
Number of subjects: 14
Study 28993264 — intervention group
Group type: COMPARATOR
Intervention: Muscarinic-antagonist component (umeclidinium - UME)
Number of subjects: 14
Study 29137696 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-knee massage with ginger oil (twice a week)
Number of subjects: 68
Study 26205973 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhea's method for estimating pneumothorax size
Number of subjects: 80
Study 26205973 — intervention group
Group type: EXPERIMENTAL
Intervention: Choi's method for estimating pneumothorax size
Number of subjects: 80
Study 23953645 — intervention group
Group type: EXPERIMENTAL
Intervention: POL (P/S ratio 0.27)
Number of subjects: 15
Study 23953645 — intervention group
Group type: COMPARATOR
Intervention: AHA (P/S ratio 1.00)
Number of subjects: 15
Study 23953645 — intervention group
Group type: EXPERIMENTAL
Intervention: PCAN (P/S ratio 1.32)
Number of subjects: 15
Study 22162649 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 5
Study 22162649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 5
Study 19032134 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupirtine 100 mg three times daily for 5-7 days
Number of subjects: 209
Study 19032134 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 50 mg three times daily for 5-7 days
Number of subjects: 209
Study 17115157 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5438 60 mg
Number of subjects: 23
Study 17115157 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5438 80 mg
Number of subjects: 23
Study 17115157 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5438 160 mg
Number of subjects: 23
Study 17115157 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5438 (various doses)
Number of subjects: 23
Study 17115157 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5438
Number of subjects: 23
Study 15020389 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to clinical guidelines via the Internet or CD-ROM (Intervention group, n = 38)
Number of subjects: 72
Study 15020389 — intervention group
Group type: COMPARATOR
Intervention: Not having access to clinical guidelines (Control group, n = 34)
Number of subjects: 72
Study 11357205 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved water container with a cover and a spout
Number of subjects: 400
Study 11357205 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard water collection method)
Number of subjects: 400
Study 9143791 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin (n = 7)
Number of subjects: 14
Study 9143791 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 14
Study 8094111 — intervention group
Group type: EXPERIMENTAL
Intervention: Active taper (prednisolone 5 mg tablets)
Number of subjects: 35
Study 8094111 — intervention group
Group type: COMPARATOR
Intervention: Placebo taper (identical placebo tablets)
Number of subjects: 35
Study 8094111 — intervention group
Group type: EXPERIMENTAL
Intervention: Active taper
Number of subjects: 35
Study 3304600 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam plus ticarcillin
Number of subjects: 83
Study 3304600 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin plus ticarcillin
Number of subjects: 83
Study 30909214 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit blood pressure variability (VVV)
Number of subjects: 392
Study 30909214 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure coefficient of variation (CV)
Number of subjects: 392
Study 29247782 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation with 1000 IU of vitamin D and 500 mg of calcium for six months
Number of subjects: 106
Study 29247782 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation with 1000 IU of vitamin D and 500 mg of calcium
Number of subjects: 106
Study 26712558 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (theophylline salt formulation)
Number of subjects: 71
Study 24422912 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-session rTMS conditioning with 10-session 1 Hz rTMS over contralesional M1 followed by 10-session iTBS over ipsilesional M1
Number of subjects: 48
Study 24422912 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation identical to Group A
Number of subjects: 48
Study 24422912 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-session rTMS conditioning with 10-session iTBS over ipsilesional M1 followed by 10-session 1 Hz rTMS over contralesional M1
Number of subjects: 48
Study 22564353 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 159
Study 20193093 — intervention group
Group type: EXPERIMENTAL
Intervention: cNFO (northern fish oil with high POP content)
Number of subjects: 3
Study 20193093 — intervention group
Group type: EXPERIMENTAL
Intervention: deNFO (decontaminated northern fish oil)
Number of subjects: 3
Study 20193093 — intervention group
Group type: EXPERIMENTAL
Intervention: SFO/RO/SO (blend of southern fish oil, rapeseed and soybean oils)
Number of subjects: 3
Study 18268511 — intervention group
Group type: EXPERIMENTAL
Intervention: Atkins diet
Number of subjects: 181
Study 18268511 — intervention group
Group type: EXPERIMENTAL
Intervention: Zone diet
Number of subjects: 181
Study 18268511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornish diet
Number of subjects: 181
Study 15673389 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress produced by Stroop's color word conflict test (CWT)
Number of subjects: 23
Study 15673389 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic tone inhibition (ATI) with propranolol (0.15 mg/kg) and atropine (0.02 mg/kg)
Number of subjects: 23
Study 12149603 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium alginate dressing
Number of subjects: 77
Study 12149603 — intervention group
Group type: COMPARATOR
Intervention: Vaseline gauze dressing
Number of subjects: 77
Study 10208192 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol (42 microg twice daily)
Number of subjects: 411
Study 10208192 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium bromide (36 microg four times a day)
Number of subjects: 411
Study 10208192 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo (2 puffs four times a day)
Number of subjects: 411
Study 10208192 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol
Number of subjects: 411
Study 7788426 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atovaquone for mild to moderate PCP
Number of subjects: 940
Study 7788426 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atovaquone for severe PCP
Number of subjects: 940
Study 2082317 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 128
Study 2082317 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 128
Study 2082317 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg plus Codeine 60 mg
Number of subjects: 128
Study 2082317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 402794 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH 600 mug
Number of subjects: 10
Study 402794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30219482 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified soap bar with embedded toys, delivered in a fun, interactive household session with minimal messaging.
Number of subjects: 80
Study 30219482 — intervention group
Group type: COMPARATOR
Intervention: Plain soap delivered in a standard health-based hygiene promotion session.
Number of subjects: 80
Study 27490823 — intervention group
Group type: EXPERIMENTAL
Intervention: Ai Chi
Number of subjects: 32
Study 27490823 — intervention group
Group type: COMPARATOR
Intervention: IBAT
Number of subjects: 32
Study 27490823 — intervention group
Group type: EXPERIMENTAL
Intervention: APT (both Ai Chi and IBAT)
Number of subjects: 32
Study 25694207 — intervention group
Group type: EXPERIMENTAL
Intervention: Early renal replacement therapy (RRT) initiated after 6 hours of urine output less than 0.5 ml/kg/h
Number of subjects: 1658
Study 25694207 — intervention group
Group type: COMPARATOR
Intervention: Late renal replacement therapy (RRT) initiated after persistent (>12 h) oliguria
Number of subjects: 1658
Study 25694207 — intervention group
Group type: COMPARATOR
Intervention: Subgroup analysis of patients with preoperative renal dysfunction and CS‐AKI
Number of subjects: 1658
Study 23644347 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbuccal delivery of Naltrexone using IntelliDrug device
Number of subjects: 12
Study 23644347 — intervention group
Group type: COMPARATOR
Intervention: Per os administration of Naltrexone (50mg tablets)
Number of subjects: 12
Study 21437607 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting condition (28°C with 50% RH)
Number of subjects: 20
Study 21437607 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive heating condition (28°C with 50% RH; leg immersion in a hot tub at 42°C)
Number of subjects: 20
Study 21437607 — intervention group
Group type: EXPERIMENTAL
Intervention: Active heating condition (32°C with 70% RH; bicycle exercise)
Number of subjects: 20
Study 19934287 — intervention group
Group type: EXPERIMENTAL
Intervention: Telomere length measured by monochrome multiplex quantitative PCR
Number of subjects: 214
Study 17822977 — intervention group
Group type: EXPERIMENTAL
Intervention: Periocular corticosteroid injection before photodynamic therapy (PDT)
Number of subjects: 67
Study 17822977 — intervention group
Group type: COMPARATOR
Intervention: PDT alone (no corticosteroid)
Number of subjects: 67
Study 17822977 — intervention group
Group type: EXPERIMENTAL
Intervention: Periocular corticosteroid injection before PDT
Number of subjects: 67
Study 15147802 — intervention group
Group type: EXPERIMENTAL
Intervention: Three pharmaceutical preparations with different tablet disintegration times
Number of subjects: 0
Study 11403536 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs) as part of H. pylori eradication therapy
Number of subjects: 0
Study 9742976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment with sulphonylureas or insulin
Number of subjects: 3867
Study 9742976 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpropamide
Number of subjects: 3867
Study 9742976 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 3867
Study 9742976 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 3867
Study 9742976 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 3867
Study 9742976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (overall)
Number of subjects: 3867
Study 8048498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex) + Spironolactone (Spi) (200 mg)
Number of subjects: 0
Study 8048498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex) + Mifepristone (Mif) (400 mg)
Number of subjects: 0
Study 8048498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex)
Number of subjects: 0
Study 8048498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3053314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral testosterone treatment
Number of subjects: 221
Study 3053314 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 221